These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1165 related items for PubMed ID: 18379010

  • 1. Minimal residual disease detection in mantle cell lymphoma: methods and significance of four-color flow cytometry compared to consensus IGH-polymerase chain reaction at initial staging and for follow-up examinations.
    Böttcher S, Ritgen M, Buske S, Gesk S, Klapper W, Hoster E, Hiddemann W, Unterhalt M, Dreyling M, Siebert R, Kneba M, Pott C, EU MCL MRD Group.
    Haematologica; 2008 Apr; 93(4):551-9. PubMed ID: 18379010
    [Abstract] [Full Text] [Related]

  • 2. Rituximab induces effective clearance of minimal residual disease in molecular relapses of mantle cell lymphoma.
    Ladetto M, Magni M, Pagliano G, De Marco F, Drandi D, Ricca I, Astolfi M, Matteucci P, Guidetti A, Mantoan B, Bodoni CL, Zanni M, Boccadoro M, Gianni AM, Tarella C.
    Biol Blood Marrow Transplant; 2006 Dec; 12(12):1270-6. PubMed ID: 17162208
    [Abstract] [Full Text] [Related]

  • 3. Combined polymerase chain reaction methods to detect c-myc/IgH rearrangement in childhood Burkitt's lymphoma for minimal residual disease analysis.
    Busch K, Borkhardt A, Wössmann W, Reiter A, Harbott J.
    Haematologica; 2004 Jul; 89(7):818-25. PubMed ID: 15257933
    [Abstract] [Full Text] [Related]

  • 4. Polymerase chain reaction detection of cells carrying t(14;18) in bone marrow of patients with follicular and diffuse large B-cell lymphoma: the importance of analysis at diagnosis and significance of long-term follow-up.
    Papajík T, Jedlicková K, Kriegová E, Jarosová M, Raida L, Faber E, Hubácek J, Vondráková J, Pikalová Z, Indrák K.
    Neoplasma; 2001 Jul; 48(6):501-5. PubMed ID: 11949845
    [Abstract] [Full Text] [Related]

  • 5. Comparative analysis of minimal residual disease detection using four-color flow cytometry, consensus IgH-PCR, and quantitative IgH PCR in CLL after allogeneic and autologous stem cell transplantation.
    Böttcher S, Ritgen M, Pott C, Brüggemann M, Raff T, Stilgenbauer S, Döhner H, Dreger P, Kneba M.
    Leukemia; 2004 Oct; 18(10):1637-45. PubMed ID: 15343348
    [Abstract] [Full Text] [Related]

  • 6. Combined use of reverse transcriptase polymerase chain reaction and flow cytometry to study minimal residual disease in Philadelphia positive acute lymphoblastic leukemia.
    Muñoz L, López O, Martino R, Brunet S, Bellido M, Rubiol E, Sierra J, Nomdedéu JF.
    Haematologica; 2000 Jul; 85(7):704-10. PubMed ID: 10897122
    [Abstract] [Full Text] [Related]

  • 7. The bcl-2/IgH rearrangement in a population of 204 healthy individuals: occurrence, age and gender distribution, breakpoints, and detection method validity.
    Schmitt C, Balogh B, Grundt A, Buchholtz C, Leo A, Benner A, Hensel M, Ho AD, Leo E.
    Leuk Res; 2006 Jun; 30(6):745-50. PubMed ID: 16297448
    [Abstract] [Full Text] [Related]

  • 8. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation.
    Sánchez ML, Almeida J, Vidriales B, López-Berges MC, García-Marcos MA, Moro MJ, Corrales A, Calmuntia MJ, San Miguel JF, Orfao A.
    Leukemia; 2002 Aug; 16(8):1460-9. PubMed ID: 12145686
    [Abstract] [Full Text] [Related]

  • 9. Investigation of bone marrow involvement in malignant lymphoma using fluorescence in situ hybridization: possible utility in the detection of micrometastasis.
    Huh HJ, Min HC, Cho HI, Chae SL, Lee DS.
    Cancer Genet Cytogenet; 2008 Oct; 186(1):1-5. PubMed ID: 18786435
    [Abstract] [Full Text] [Related]

  • 10. Combined molecular diagnosis of B-cell lymphomas with t(11;14)(q13;q32) or t(14;18)(q32;q21) using multiplex- and long distance inverse-polymerase chain reaction.
    Vieira L, Martinho A, Antunes O, Silva E, Ambrósio AP, Geraldes MC, Nascimento R, Silva C, Pereira JM, Júnior EC, Jordan P.
    Diagn Mol Pathol; 2008 Jun; 17(2):73-81. PubMed ID: 18382373
    [Abstract] [Full Text] [Related]

  • 11. Detection of t(14;18) by PCR of IgH/BCL2 fusion gene in follicular lymphoma from archived cytological smears.
    Stoos-Veić T, Livun A, Ajduković R, Pejsa V, Jaksić O, Kusec R.
    Coll Antropol; 2010 Jun; 34(2):425-9. PubMed ID: 20698113
    [Abstract] [Full Text] [Related]

  • 12. [Clinical significance in detection of immunoglobulin heavy chain clonal rearrangement in bone marrow of patients with B cell lymphoma].
    Chen ZY, Zhou XY, Zhang TM, Hong XN, Yin JL, Hu XC, Shi DR.
    Zhonghua Zhong Liu Za Zhi; 2009 Mar; 31(3):183-8. PubMed ID: 19615255
    [Abstract] [Full Text] [Related]

  • 13. Comparative analysis of immunoglobulin polymerase chain reaction and flow cytometry in fine needle aspiration biopsy differential diagnosis of non-Hodgkin B-cell lymphoid malignancies.
    Maroto A, Martinez M, Martinez MA, de Agustin P, Rodriguez-Peralto JL.
    Diagn Cytopathol; 2009 Sep; 37(9):647-53. PubMed ID: 19306424
    [Abstract] [Full Text] [Related]

  • 14. Commercial LightCycler-based quantitative real-time PCR compared to nested PCR for monitoring of Bcl-2/IgH rearrangement in patients with follicular lymphoma.
    Kornacker M, Kornacker B, Schmitt C, Leo E, Ho AD, Hensel M.
    Ann Hematol; 2009 Jan; 88(1):43-50. PubMed ID: 18636259
    [Abstract] [Full Text] [Related]

  • 15. Stem cell transplantation in poor-risk chronic lymphocytic leukemia: assessment of post-transplant minimal residual disease using four- and six-color flow cytometry and allele-specific RQ-PCR.
    Itälä M, Huhtinen AR, Juvonen V, Kairisto V, Pelliniemi TT, Penttilä TL, Rauhala A, Tienhaara A, Remes K.
    Eur J Haematol; 2008 Aug; 81(2):100-6. PubMed ID: 18410542
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Common consensus LNA probe for quantitative PCR assays in cancer: vehicles for minimal residual disease detection in t(11;14) and t(14;18) positive malignant lymphomas.
    Sørensen CD, Jørgensen JM, Nederby L, Hokland P, Nyvold CG.
    J Immunol Methods; 2014 Apr; 406():131-6. PubMed ID: 24631717
    [Abstract] [Full Text] [Related]

  • 18. [Minimal residual disease in follicular and mantle cell lymphoma. Detection using quantitative molecular monitoring of circulating lymphoma cells].
    Schüler F, Hirt C, Dölken L, Krüger W, Dölken G.
    Dtsch Med Wochenschr; 2005 Sep 23; 130(38):2130-4. PubMed ID: 16172952
    [Abstract] [Full Text] [Related]

  • 19. LightCycler-based quantitative real-time PCR monitoring of patients with follicular lymphoma receiving rituximab in combination with conventional or high-dose cytotoxic chemotherapy.
    Martin S, Fischer C, Free M, Kurreck B, Stockinger H, Fenk R, Arnold C, Kliszewski S, Meckenstock G, Haas R, Kronenwett R.
    Eur J Haematol; 2005 Apr 23; 74(4):282-92. PubMed ID: 15777339
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 59.